Where are the opportunities for the development of the vaccine industry in the post-epidemic era?

The scattered outbreaks of the epidemic failed to prevent the CIIE from coming as scheduled
.

But under the influence of the epidemic, vaccines, epidemics, and public health have gained more public attention
.

In the CIIE Medical Center, the audience who stopped at the Sanofi Pasteur exhibition area noticed a smart unmanned vaccination cabin called "Miao Xiaobai"
.

Sanofi Pasteur Smart Unmanned Vaccination Chamber

This is already the second time that Sanofi Pasteur has demonstrated a smart unmanned vaccination pod during the CIIE
.

According to the knowledge of the E-medicine manager at the booth, the new generation of vaccination cabins has realized full automation; the process is sterile and safe; compared with the traditional vaccination space, it occupies a smaller area
.

The creation of "smart" services is part of the "new health formula" for vaccine innovation announced by Sanofi Pasteur during the CIIE.
Its goal is to focus on the future, focus on global and local innovation practices, and resolve industrial contradictions.
Contribute to public health
.

01.
Triple contradictions in the vaccine industry

For a long time, Sanofi Pasteur hopes to achieve energy output by continuously improving its understanding of the vaccine industry and predicting the future trends of the industry to achieve energy output and help the vaccine industry in the new policy environment.
Benign development
.

In fact, Sanofi Pasteur’s similar work began before the epidemic, but as the epidemic spreads around the world, it has more realistic soil for the transmission of its ideas
.

As we all know, the "Healthy China 2030 Planning Outline" has emphasized that in the next 10 years, persisting in focusing on prevention, realizing the advancement of disease prevention barriers, improving major epidemic prevention and control systems and mechanisms, and improving the national public health system will be China's realization of "healthy China".
2030" key strategic deployment
.

The outbreak of the new crown epidemic in early 2020 has made all countries, including China, aware of the severe economic and social damage caused by the pandemic of infectious diseases
.

The vaccine industry is an important part of the public health service system, but because its target users are different from drugs, most of its users are healthy people, and because of the differences in different ethnic groups, vaccine products are being developed, produced, and circulated.
Supervision and management are more stringent
.

Therefore, there have been three contradictions in the development of the vaccine industry:

The first is the contradiction between the importance of public prevention and the level of immunity
.

The second is the contradiction between market demand for diversified vaccines and vaccine access
.

Thirdly, due to the limitation of vaccination scenarios, there are some contradictions between the workload and work efficiency of disease control vaccination points
.

As the first multinational vaccine company to enter China, Sanofi Pasteur has been actively participating in and promoting the development of preventive immunization in China
.

02.
Sanofi Pasteur vaccine innovation

"New Health Formula"

Although "addition, subtraction, multiplication and division" have different connotations, they have constructed a system of ideas and behaviors from top to bottom and from the inside out
.

The connotation of "Plus" is "digital technology blessing"
.

Sanofi Pasteur and Olive Branch Signing Ceremony

The connotation of "reduction" is to reduce industrial barriers
.

"On the one hand, more innovative vaccines, more advanced technologies, and more knowledge and experience will be introduced to the mainland through the Greater Bay Area, the'gateway' of China’s opening and development; Link innovation and upgrading, and continuously strengthen cooperation and innovation with all walks of life, industry, academia, research, and use.
With a proactive and innovative-led attitude, we will work with all walks of life to find the best solution for vaccine innovation
.
" Zhang Heping told the E-pharmaceutical manager
.

The connotation of "multiplication" is to help realize "Healthy China 2030" and to protect public health throughout the life cycle
.

At the CIIE, Sanofi Pasteur showcased three blockbuster vaccine products and prevention methods, which are the world’s first and currently the only approved recombinant quadrivalent influenza vaccine Flublok, and the world’s first It can be widely used in infants and young children to prevent respiratory syncytial virus (RSV) infection
.

Sanofi Pasteur Expo Innovative Products

"Sanofi Pasteur currently has 4 products in China, but it has more than 20 products worldwide, and also has more than 10 products under development
.
We hope that we can use the platform of the China International Import Expo to make the world's leading High-quality vaccines are introduced into the country
.
" Zhang Heping said
.

The connotation of "elimination" is to eliminate cognitive blind spots
.
At the CIIE, Sanofi Pasteur and the Chinese Preventive Medicine Association jointly launched the "Baby Care Action-Obstetrics and Pediatric Health Education" project to improve the professional capabilities of medical staff and the health literacy of parents of newborns, and enhance children to complete all stages of vaccines The degree of inoculation coordination
.
At the same time, Sanofi Pasteur also signed a strategic cooperation agreement with the Peking University Public Health and Major Epidemic Prevention and Control Strategy Research Center to jointly explore new ideas for prevention and immunity, help China's public health professional capacity and system upgrade, and enhance respiratory infections Disease detection capabilities
.

Sanofi Pasteur and the Chinese Preventive Medicine Association Cloud Signing Ceremony

Sanofi Pasteur and Peking University Strategic Center Signing Ceremony

The establishment of a sound public health operation system and the introduction of more diversified vaccine innovation products to help public health require the joint efforts of the government and the business community.
“In the future, I hope the government will continue to promote the priority review and approval system for innovative vaccines; In the field of management and management, it is encouraged to be in line with international standards; for innovative technologies and products that can be used to respond to public health emergencies, a full range of policy support is provided in the top-level design and industrial layout
.
" Zhang Heping said
.